cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Geron Corporation
32 own
41 watching
Current Price
$3.2
$-0.03
(-0.93%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,219.89M
52-Week High
52-Week High
3.84
52-Week Low
52-Week Low
0.9983
Average Volume
Average Volume
4.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,219.89M
icon52-Week High3.84
icon52-Week Low0.9983
iconAverage Volume4.6M
iconDividend Yield--
iconP/E Ratio--
What does the Geron Corporation do?
Geron Corporation operates as a biopharmaceutical company. The company supports the clinical stage development of a telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.
Read More
How much money does Geron Corporation make?
News & Events about Geron Corporation.
Ticker Report
10days ago
StockNews.com upgraded shares of Geron (NASDAQ:GERN Get Rating) to a sell rating in a report released on Thursday morning. Other analysts have also issued reports about the stock. Wedbush increased their price objective on shares of Geron from $5.00 to $6.00 and gave the stock an outperform ...
Globe Newswire
22days ago
NEW YORK, Jan. 16, 2023 (GLOBE NEWSWIRE) -- UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA JULIA JUNGE and RICHARD JUNGE, on behalf ofthemselves and a class of similarly situated investors, Plaintiffs, v.GERON CORPORATION and JOHN A. SCARLETT, Defendants. Case No.: 3:20-cv-00547-WHA (...
Business Wire
27days ago
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Gerons Chairman and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the B. Riley Securities 3rd Annual Virtual Oncology Conference on...
Business Wire
28days ago
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today highlighted multiple additions to its senior commercial leadership team, as it prepares for the potential commercialization in the U.S. market of imetelstat, a first-in-class telomerase inhibitor. Key additions...
Frequently Asked Questions
Frequently Asked Questions
What is Geron Corporation share price today?
plus_minus_icon
Can Indians buy Geron Corporation shares?
plus_minus_icon
How can I buy Geron Corporation shares from India?
plus_minus_icon
Can Fractional shares of Geron Corporation be purchased?
plus_minus_icon
What are the documents required to start investing in Geron Corporation stocks?
plus_minus_icon
What is today’s traded volume of Geron Corporation?
plus_minus_icon
What is today’s market capitalisation of Geron Corporation?
plus_minus_icon
What is the 52-Week High and Low Range of Geron Corporation?
plus_minus_icon
What percentage is Geron Corporation down from its 52-Week High?
plus_minus_icon
What percentage is Geron Corporation up from its 52-Week Low?
plus_minus_icon
Current Price
$3.2
$-0.03
(-0.93%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00